Search This Blog

Wednesday, March 4, 2020

Recro Pharma EPS beats by $0.76, misses on revenue

Recro Pharma (NASDAQ:REPH): FY GAAP EPS of $0.20 beats by $0.76.
Revenue of $99.22M (+28.3% Y/Y) misses by $2.09M.
Press Release
https://seekingalpha.com/news/3548461-recro-pharma-eps-beats-0_76-misses-on-revenue
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)